Magnetic Resonance Imaging in Myocardial Fibrosis Related to Ischemic Events

1. Maron MS. Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy. Journal of Cardiovascular Magnetic Resonance. 2012;14:13.10.1186/1532-429X-14-13Open DOISearch in Google Scholar

2. Menghetti L, Basso C, Nava A, Angelini A, Thiene G. Spin-echo nuclear magnetic resonance for tissue characterisation in arrhythmogenic right ventricular cardiomyopathy. Heart. 1996;76:467-470.10.1136/hrt.76.6.467Open DOISearch in Google Scholar

3. Beerbaum P, Körperich H, Barth P, Esdorn H, Gieseke J, Meyer H. Noninvasive quantification of left-to-right shunt in pediatric patients: phase-contrast cine magnetic resonance imaging compared with invasive oximetry. Circulation. 2001;103:2476-2482.10.1161/01.CIR.103.20.2476Search in Google Scholar

4. Sayad DE, Willett DL, Bridges WH, et al. Noninvasive quantitation of left ventricular wall thickening using cine magnetic resonance imaging with myocardial tagging. Am J Cardiol. 1995;76:985-989.10.1016/S0002-9149(99)80280-XOpen DOISearch in Google Scholar

5. Hundley WG, Meshack BM, Willett DL, et al. Comparison of quantitation of left ventricular volume, ejection fraction, and cardiac output in patients with atrial fibrillation by cine magnetic resonance imaging versus invasive measurements. Am J Cardiol. 1996;78:1119-1123.10.1016/S0002-9149(96)90063-6Open DOISearch in Google Scholar

6. Olin JW, Kaufman JA, Bluemke DA, et al. Atherosclerotic Vascular Disease Conference: Writing Group IV: imaging. Circulation. 2004;109:2626-2633.10.1161/01.CIR.0000128521.02390.72Search in Google Scholar

7. Spittell PC, Spittell JA Jr, Joyce JW, et al. Clinical features and differential diagnosis of aortic dissection: experience with 236 cases (1980 through 1990). Mayo Clinic Proceedings. 1993;68:642-651.10.1016/S0025-6196(12)60599-0Search in Google Scholar

8. Sechtem U, Tscholakoff D, Higgins CB. MRI of the normal pericardium. AJR Am J Roentgenol. 1986;147:239-244.10.2214/ajr.147.2.239Search in Google Scholar

9. Breen JF. Imaging of the pericardium. J Thorac Imaging. 2001;16:47-54.10.1097/00005382-200101000-00007Search in Google Scholar

10. Kojima S, Yamada N, Goto Y. Diagnosis of constrictive pericarditis by tagged cine magnetic resonance imaging. N Engl J Med. 1999;341:373-374.10.1056/NEJM199907293410515Search in Google Scholar

11. Masui T, Finck S, Higgins CB. Constrictive pericarditis and restrictive cardiomyopathy: evaluation with MR imaging. Radiology. 1992;182:369-373.10.1148/radiology.182.2.1732952Search in Google Scholar

12. Yu EH, Sloggett CE, Iwanochko RM, Rakowski H, Siu SC. Feasibility and accuracy of left ventricular volumes and ejection fraction determination by fundamental, tissue harmonic, and intravenous contrast imaging in difficult-to-image patients. J Am Soc Echocardiogr. 2000; 13:216-224.10.1067/mje.2000.103597Search in Google Scholar

13. Kim RJ, Albert TS, Wible JH, et al. Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial. Circulation. 2008;117:629-637.10.1161/CIRCULATIONAHA.107.723262Search in Google Scholar

14. Wagner A, Mahrholdt H, Holly TA, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet. 2003;361:374-379.10.1016/S0140-6736(03)12389-6Search in Google Scholar

15. Thiele H, Kappl MJ, Conradi S, Niebauer J, Hambrecht R, Schuler G. Reproducibility of chronic and acute infarct size measurement by delayed enhancement-magnetic resonance imaging. J Am Coll Cardiol. 2006;47:1641-1645.10.1016/j.jacc.2005.11.065Open DOISearch in Google Scholar

16. Rochitte CE, Lima JA, Bluemke DA, et al. Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction. Circulation. 1998;98:1006-1014.10.1161/01.CIR.98.10.1006Open DOISearch in Google Scholar

17. Kumar A, Abdel-Aty H, Kriedemann I, et al. Contrast-enhanced cardiovascular magnetic resonance imaging of right ventricular infarction. J Am Coll Cardiol. 2006;48:1969-1976.10.1016/j.jacc.2006.05.078Open DOISearch in Google Scholar

18. Klein C, Nekolla SG, Bengel FM, et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation. 2002;105:162-167.10.1161/hc0202.102123Search in Google Scholar

19. Yan AT, Shayne AJ, Brown KA, et al. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation. 2006;114:32-39.10.1161/CIRCULATIONAHA.106.613414Search in Google Scholar

20. Flett AS, Hayward MP, Ashworth MT, et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation. 2010;122:138-144.10.1161/CIRCULATIONAHA.109.930636Search in Google Scholar

21. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100:1992-2002.10.1161/01.CIR.100.19.1992Open DOISearch in Google Scholar

22. Wu KC, Zerhouni EA, Judd RM, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation. 1998;97:765-772.10.1161/01.CIR.97.8.765Open DOISearch in Google Scholar

23. Taylor AJ, Al-Saadi N, Abdel-Aty H, Schulz-Menger J, Messroghli DR, Friedrich MG. Detection of acutely impaired microvascular reperfusion after infarct angioplasty with magnetic resonance imaging. Circulation. 2004;109:2080-2085.10.1161/01.CIR.0000127812.62277.50Search in Google Scholar

24. Tarantini G, Cacciavillani L, Corbetti F, et al. Duration of ischemia is a major determinant of transmurality and severe microvascular obstruction after primary angioplasty: a study performed with contrast-enhanced magnetic resonance. J Am Coll Cardiol. 2005;46:1229-1235.10.1016/j.jacc.2005.06.054Open DOISearch in Google Scholar

25. Rochitte CE, Oliveira PF, Andrade JM, et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity. J Am Coll Cardiol. 2005;46:1553-1558.10.1016/j.jacc.2005.06.067Open DOISearch in Google Scholar

26. Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J. 2010;31:806-814.10.1093/eurheartj/ehq025Open DOISearch in Google Scholar

27. SenChowdhry S, Prasad SK, Syrris P, et al. Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited: comparison with task force criteria and genotype. J Am Coll Cardiol. 2006;48:2132-2140.10.1016/j.jacc.2006.07.045Open DOISearch in Google Scholar

28. January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrialfibrillation: executive summary: a report of the American College of Cardiology/American Heart Association TaskForce on practice guidelines and the Heart Rhythm Society. Circulation. 2014;130:2071-2104.10.1161/CIR.0000000000000040Search in Google Scholar